Spicy Diet on Salty Taste and Salt Intake
Effects of Spicy Diet on Salty Taste and Salt Intake
2 other identifiers
observational
606
1 country
1
Brief Summary
Excess dietary salt intake is closely associated with the development of hypertension and cardiocerebral vascular diseases. Reduction in high salt intake significantly prevents hypertension and cardiocerebral events. Currently, few promising method is available to reduce salt intake in human. This study focus on examining the salty taste in population-level and exploring whether dietary factors can reduce salt intake through acting on salty taste.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 27, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedFirst Posted
Study publicly available on registry
November 13, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedJanuary 11, 2016
January 1, 2016
9 months
October 27, 2013
January 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effects of spicy diet on salt taste
Daily spicy food intake was evaluated by diet questionnaire and salty taste was tested through salt perception and super-threshold examination on the first day when the participant was investigated.
Day 1
Secondary Outcomes (3)
Effects of spicy diet on salt intake
Day 1
Effects of spicy diet on obesity parameters.
Day 1
Effects of spicy diet on blood pressure
Day 1
Study Arms (1)
Different degree of spicy food intake
Interventions
Eligibility Criteria
Residents from four cities(Shenyang, Jinan, Chengdu and Chongqing) in China
You may qualify if:
- Age ≥ 18 years and ≤ 55 years.
- Willing and able to provide written informed consent.
- Willing and able to comply with all study procedures.
You may not qualify if:
- Hypogeusia or loss due to neural system disease or oral and digestive disease.
- Capsaicin allergy and poor compliance.
- Recently oral diuretics and participate in other pharmacological experiment in 3 months.
- Acute infection, cancer, serious arrhythmias, drug or alcohol abuse.
- Currently have cold, fever, acidosis, dehydration, diarrhea, vomiting during the study.
- Unwilling or unable to communication due to the dysnoesia and language disorders
- Severe neural or psychiatric diseases that would preclude fully understand and corporation in the study.
- Pregnancy or lactation
- Unwilling to sign the informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhiming Zhulead
Study Sites (1)
Daping Hospital, The Third Military Medical University
Chongqing, Chongqing Municipality, 400042, China
Related Publications (3)
Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab. 2010 Aug 4;12(2):130-41. doi: 10.1016/j.cmet.2010.05.015.
PMID: 20674858RESULTZhang LL, Yan Liu D, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, Schrader M, Thilo F, Zhu ZM, Tepel M. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res. 2007 Apr 13;100(7):1063-70. doi: 10.1161/01.RES.0000262653.84850.8b. Epub 2007 Mar 8.
PMID: 17347480RESULTHao X, Chen J, Luo Z, He H, Yu H, Ma L, Ma S, Zhu T, Liu D, Zhu Z. TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in mice. Pflugers Arch. 2011 Mar;461(3):345-53. doi: 10.1007/s00424-011-0921-x. Epub 2011 Jan 19.
PMID: 21246380RESULT
Biospecimen
Blood, Urine
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of the Dept. of Hypertension & Endocrinology
Study Record Dates
First Submitted
October 27, 2013
First Posted
November 13, 2013
Study Start
February 1, 2013
Primary Completion
November 1, 2013
Study Completion
December 1, 2013
Last Updated
January 11, 2016
Record last verified: 2016-01